Form 8-K - Current report:
SEC Accession No. 0001654954-19-014199
Filing Date
2019-12-26
Accepted
2019-12-26 08:03:12
Documents
7
Period of Report
2019-12-23
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT cvm_8k.htm 8-K 35789
2 UNDERWRITING AGREEMENT cvm_ex1-1.htm EX-1.1 344433
3 OPINION OF HART & HART, LLC cvm_ex5-1.htm EX-5.1 7000
4 CONSENT OF HART & HART, LLC cvm_ex23-1.htm EX-23.1 5201
5 PRESS RELEASE DATED DECEMBER 24, 2019 cvm_e99-1.htm EX-99.1 14065
6 IMAGE cvm_ex5-1000.jpg GRAPHIC 8830
7 IMAGE img01.jpg GRAPHIC 8105
  Complete submission text file 0001654954-19-014199.txt   431330
Mailing Address 8229 BOONE BLVD. SUITE 802 VIENNA VA 22182
Business Address 8229 BOONE BLVD . SUITE 802 VIENNA VA 22182 7035069460
CEL SCI CORP (Filer) CIK: 0000725363 (see all company filings)

EIN.: 840916344 | State of Incorp.: CO | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-11889 | Film No.: 191308377
SIC: 2836 Biological Products, (No Diagnostic Substances)